High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma.

Abstract

Prolonged failure-free survival is possible following high-dose therapy and autologous hematopoietic rescue for follicular low-grade lymphoma. It is unclear whether patients are cured with this therapy or if survival is prolonged.